Drugs / IVOSPEMIN

Trials 7 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT03412799 Jun 2018 → Feb 2022 pancreatic ductal adenocarcinoma Panbela Therapeutics, Inc. Completed No outcome recorded
Phase 1 NCT02657330 Jan 2016 → Oct 2017 pancreatic ductal adenocarcinoma Panbela Therapeutics, Inc. Completed No outcome recorded
Phase 21 trial
Phase 2 NCT02038829 Jan → May 2014 chronic obstructive pulmonary disease Sunovion Respiratory Development Inc. Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT05254171 Aug 2022 → Aug 2026 overdue pancreatic ductal adenocarcinoma Panbela Therapeutics, Inc. Recruiting No outcome recorded
Phase 33 trials
Phase 3 NCT02347774 Feb → Dec 2015 chronic obstructive pulmonary disease Sunovion Respiratory Development Inc. Completed No outcome recorded
Phase 3 NCT02347761 Feb → Nov 2015 chronic obstructive pulmonary disease Sunovion Respiratory Development Inc. Completed No outcome recorded
Phase 3 NCT02276222 Oct 2014 → Feb 2016 chronic obstructive pulmonary disease Sunovion Respiratory Development Inc. Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as IVOSPEMIN ChEMBL registry synonym — accepted as the source's own label CHEMBL80386
Known as IVOSPEMIN HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL80386
Known as Ivospemin tetrahydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL80386
Known as Longhala Magnair “Longhala™ Magnair™ (glycopyrrolate) Inhalation Solution, a drug/device combination of the long-acting antimuscarinic glycopyrrolate administered using the eFlow® closed system...” PMID 30584583 Jun 2018
Known as SBP-101 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02657330
2

NCT03412799

NCT05254171

Known as SBP-101 TETRAHYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL80386
Known as SUN-101 SUN-101 3 mcg bid” NCT02038829
3

NCT02276222

NCT02347761

NCT02347774

Modality Other / unclassified “a drug/device combination of the long-acting antimuscarinic glycopyrrolate administered using the eFlow® closed system (eFlow CS) nebulizer” PMID 30584583 Jun 2018
Route Inhaled “via eFlow Closed System (CS) nebulizer” NCT02276222